查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1728150

关节痛注射市场－全球产业规模、份额、趋势、机会和预测（按註射类型、应用、地区和竞争细分，2020-2030 年）

Joint Pain Injections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Injection, By Application, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球关节痛注射市场价值为 46.6 亿美元，预计将出现强劲增长，到 2030 年达到巨大的市场潜力，复合年增长率为 7.02%。这个市场领域迎合了全球性内骨关节炎和类风湿性关节炎等关节相关疾病发生率不断上升的需求。关节疼痛注射为治疗慢性关节疼痛和发炎提供了一种微创且有效的手术替代方法。这些治疗包括皮质类固醇、透明质酸、富血小板血浆 (PRP) 和胎盘组织基质注射，旨在减轻疼痛、改善活动能力并增强整体关节功能。全球人口老化和对非手术治疗方案的需求不断增加正在加速市场扩张。

市场概览
预测期 2026-2030
2024年市场规模 46.6亿美元
2030年市场规模 69.5亿美元
2025-2030 年复合年增长率 7.02%
成长最快的领域 玻尿酸注射
最大的市场 北美洲

关键市场驱动因素

肥胖率上升

主要市场挑战

报销问题

主要市场趋势

生物製剂和再生疗法的进展

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球关节痛注射市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依注射类型（类固醇关节注射、透明质酸注射、富血小板血浆 (PRP) 注射、胎盘组织基质 (PTM) 注射、其他）
    • 依应用（肩关节和肘关节、膝关节和踝关节、脊椎关节、髋关节、其他）
    • 按地区
    • 按公司分类（2024）
  • 市场地图
    • 按註射类型
    • 按应用
    • 按地区

第六章：北美关节痛注射市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章：欧洲关节痛注射剂市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙

第八章：亚太地区关节痛注射市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国

第九章：南美关节痛注射市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章：中东与非洲关节痛注射市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 科威特

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 14 章：竞争格局

  • Anika Therapeutics Inc
  • Bioventus LLC
  • Ferring Pharmaceuticals Inc
  • Sanofi SA
  • Pfizer Inc
  • Eli Lilly & Co
  • Flexion Therapeutics Inc
  • Teva Pharmaceutical Industries Ltd
  • Zimmer Biomet Holdings, Inc.

第 15 章：策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 20639

The Global Joint Pain Injections Market was valued at USD 4.66 billion in 2024 and is expected to witness robust growth, reaching significant market potential by 2030 with a CAGR of 7.02%. This market segment caters to the rising global incidence of joint-related disorders such as osteoarthritis and rheumatoid arthritis. Joint pain injections offer a minimally invasive and effective alternative to surgery for managing chronic joint pain and inflammation. These treatments include corticosteroids, hyaluronic acid, platelet-rich plasma (PRP), and placental tissue matrix injections, all designed to reduce pain, improve mobility, and enhance overall joint function. The aging global population and increasing demand for non-surgical treatment options are accelerating market expansion.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 4.66 Billion
Market Size 2030USD 6.95 Billion
CAGR 2025-20307.02%
Fastest Growing SegmentHyaluronic Acid Injections
Largest MarketNorth America

Key Market Drivers

Rising Obesity Rates

The growing prevalence of obesity is a key driver propelling the demand for joint pain injections worldwide. As obesity rates rise, so does the burden on weight-bearing joints, increasing the risk of joint disorders like osteoarthritis. According to the World Health Organization, the number of obese individuals has significantly increased over the past few decades, with over 650 million people classified as obese in 2016. Excess weight leads to greater stress on joints, resulting in chronic pain and inflammation that often necessitates medical intervention. Joint pain injections offer an effective solution for managing this discomfort and are increasingly sought after as part of long-term pain management strategies in obese populations.

Key Market Challenges

Reimbursement Issues

Reimbursement limitations pose a significant barrier to the widespread adoption of joint pain injections. In many healthcare systems, inadequate insurance coverage discourages patients from opting for injection-based therapies due to high out-of-pocket expenses. This is particularly true for newer or biologic-based treatments, which tend to be more expensive. As a result, despite clinical efficacy, limited reimbursement frameworks can hinder market growth by restricting patient access to advanced treatment options.

Key Market Trends

Advancements in Biologics and Regenerative Therapies

Technological progress in biologics and regenerative medicine is shaping a major trend in the joint pain injections market. Treatments such as platelet-rich plasma (PRP) and placental tissue matrix (PTM) injections are gaining attention for their ability to promote tissue repair and deliver extended relief from joint pain. These therapies utilize the patient's own biological components or donor-derived materials to regenerate damaged tissues, offering an innovative approach to joint restoration. Continued R&D in this area is expected to yield next-generation injectable solutions that offer superior outcomes and durability, further enhancing patient appeal and clinical adoption.

Key Market Players

  • Anika Therapeutics Inc
  • Bioventus LLC
  • Ferring Pharmaceuticals Inc
  • Sanofi SA
  • Pfizer Inc
  • Eli Lilly & Co
  • Flexion Therapeutics Inc
  • Teva Pharmaceutical Industries Ltd
  • Zimmer Biomet Holdings, Inc.

Report Scope:

In this report, the Global Joint Pain Injections Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Joint Pain Injections Market, By Type of Injection:

  • Steroid Joint Injections
  • Hyaluronic Acid Injections
  • Platelet-rich Plasma (PRP) Injections
  • Placental Tissue Matrix (PTM) Injections
  • Others

Joint Pain Injections Market, By Application:

  • Shoulder & Elbow
  • Knee & Ankle
  • Spinal Joints
  • Hip Joint
  • Others

Joint Pain Injections Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Joint Pain Injections Market.

Available Customizations:

Global Joint Pain Injections market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Joint Pain Injections Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
    • 5.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map
    • 5.3.1. By Type of Injection
    • 5.3.2. By Application
    • 5.3.3. By Region

6. North America Joint Pain Injections Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
    • 6.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Joint Pain Injections Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type of Injection
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Joint Pain Injections Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type of Injection
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Joint Pain Injections Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type of Injection
        • 6.3.3.2.2. By Application

7. Europe Joint Pain Injections Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
    • 7.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Joint Pain Injections Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Injection
        • 7.3.1.2.2. By Application
    • 7.3.2. United Kingdom Joint Pain Injections Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Injection
        • 7.3.2.2.2. By Application
    • 7.3.3. France Joint Pain Injections Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Injection
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Joint Pain Injections Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type of Injection
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Joint Pain Injections Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type of Injection
        • 7.3.5.2.2. By Application

8. Asia-Pacific Joint Pain Injections Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
    • 8.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Joint Pain Injections Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Injection
        • 8.3.1.2.2. By Application
    • 8.3.2. Japan Joint Pain Injections Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Injection
        • 8.3.2.2.2. By Application
    • 8.3.3. India Joint Pain Injections Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Injection
        • 8.3.3.2.2. By Application
    • 8.3.4. Australia Joint Pain Injections Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type of Injection
        • 8.3.4.2.2. By Application
    • 8.3.5. South Korea Joint Pain Injections Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type of Injection
        • 8.3.5.2.2. By Application

9. South America Joint Pain Injections Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
    • 9.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Joint Pain Injections Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Injection
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Joint Pain Injections Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Injection
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Joint Pain Injections Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Injection
        • 9.3.3.2.2. By Application

10. Middle East and Africa Joint Pain Injections Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
    • 10.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Joint Pain Injections Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Injection
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Joint Pain Injections Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type of Injection
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Joint Pain Injections Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Injection
        • 10.3.3.2.2. By Application
    • 10.3.4. Kuwait Joint Pain Injections Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type of Injection
        • 10.3.4.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Anika Therapeutics Inc
  • 14.2. Bioventus LLC
  • 14.3. Ferring Pharmaceuticals Inc
  • 14.4. Sanofi SA
  • 14.5. Pfizer Inc
  • 14.6. Eli Lilly & Co
  • 14.7. Flexion Therapeutics Inc
  • 14.8. Teva Pharmaceutical Industries Ltd
  • 14.9. Zimmer Biomet Holdings, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer